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ohn A. Rumberger, PHD, MD, FACC
rinceton, New Jersey
n this issue of the Journal, Budoff et al. (1) publish results
rom the ACCURACY (Assessment by Coronary Com-
uted Tomographic Angiography of Individuals Undergo-
ng Invasive Coronary Angiography) trial comparing non-
nvasive coronary computed tomography angiography
CCTA) with invasive quantitative coronary angiography
QCA) for definition of atherosclerotic luminal narrowing
t the 50% and/or 70% stenosis levels. At first glance my
eaction was, “Oh, no, not another 64-slice CT scan
validation’ report looking at sensitivity (Se)/specificity (Sp)
or finding obstructive coronary disease! Didn’t I just read a
imilar report in JACC, JAMA, Circulation, etc.!” However,
his was and is not the case.
See page 1724
In fact, the current report is a verification of what those of
s in the field have known privately, but were not prepared
o admit in public; however, allow me to comment further,
iting some unique attributes:
A multicenter investigation. The ACCURACY trial is
the combination of CCTA studies conducted in 16
different performance sites, some of which were situated
in academia, but most of which were high-quality com-
puted tomography (CT) laboratories in the private sector.
Prior published investigations of CCTA were almost
universally performed in singular, tertiary referral/aca-
demic sites where strict attention to detail is expected and
time is measured in resident and fellow hours. Not
uncommonly, busy private practices may not have ade-
quate staff and ideal patients to optimally perform some
imaging studies; this may result in inferior clinical per-
formance. However, the current investigation provided
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Division of Cardiovascular Imaging, The Princeton Longevity Center,
rinceton Forrestall Village, Princeton, New Jersey.straightforward (in fact, a generally “routine”) CCTA
application and image reconstruction protocols that
can be achieved regardless of performance site. This is
very important because duplication of similar methods
at a site using current state-of-the-art 64-slice CT
scanners (regardless of the manufacturer) is to be
highly anticipated.
Low to intermediate obstructive disease prevalence.
The data reported per patient by the ACCURACY
investigators shows that an Se and Sp for any obstructive
narrowing (using a definition of 70% focal coronary
stenosis, which is more clinically relevant for ischemic
potential than the commonly applied 50% stenosis) for
CCTA was 83% and 83%, respectively. These results
rival the best statistics for noninvasive stress imaging and,
although the positive predictive value (PPV) was only
48%, the negative predictive value (NPV) was 99%!
Interestingly, these statistics are similar to those reported
by other single-site academic centers reporting their
CCTA findings, and that fact alone is of note. However,
more importantly, the current study did not include
patients with known coronary disease, and the final tally
shows the prevalence of any70% narrowing by QCA to
be found in only 32 (14%) of the 230 patients included in
the investigation. Although these study subjects were all
recruited from individuals clinically scheduled for diag-
nostic angiography (of which at least 64% had abnormal
prior stress test results), the actual prevalence of obstruc-
tive disease ranged from low to intermediate. Prior
single-site and multi-site CCTA studies (although some
were performed using 16-slice CT) were universally
performed in individuals with known coronary artery
disease or those with very high pre-test likelihood. This
underscores 2 important points: 1) CCTA is a superb test
(99% NPV) for ruling out obstructive disease in symp-
tomatic but intermediate pre-test likelihood individuals;
and 2) the accuracy of CCTA in defining obstructive
disease is relatively independent of prevalence in the
population under investigation. This latter point requires
comment because it is well known that general noninva-
sive cardiac test accuracy (essentially stress testing with or
without imaging) is dependent on population disease
prevalence. However, CCTA, which is direct visualiza-
tion of the arteries rather than a surrogate based on
potential compromise in perfusion, compares very favor-
ably with direct visualization with angiography. To
emphasize the point, all patients who were subsequently
found to have a 70% stenosis by QCA were identified
in ACCURACY to have at least a 50% visual narrow-
ing by CCTA. In other words a report indicating no
stenosis 50% in the CCTA was 100% predictive of the
absence of a 70% by QCA!
Interpretation. The studies were interpreted indepen-
dently and separately by 3 well-known experts in CCTA.
The interpreters were free to use all variety of 2- and
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computer workstations and were not constrained to using
pre-processing algorithms that are often touted by work-
station vendors to save time. The use of any or all
interactive processing algorithms available has been
shown to be superior in CCTA interpretation to more
convenient pre-processing algorithms (2). The protocol
required agreement between 2 interpreters on a per-
patient and per-artery basis, and in only 3 cases (1.3% of
the total) was there no agreement. Standards for level II
and III CCTA competency for interpretation were put
forward by the American College of Cardiology Foun-
dation (3) in 2005 and are strictly enforced by the Society
of Cardiovascular CT on all sanctioned CCTA training
programs in the U.S. Furthermore, a certification board
examination is now established for cardiac CT by the
Certification Board of Cardiovascular Computed To-
mography (first examination, September 2008). Thus
duplication of these results is to be expected by current
and future level II- and III-qualified CCTA interpreters.
No patient exclusions. Prior published investigations
regarding the validity of CCTA often excluded unevalu-
able coronary segments, vessels of 2 mm in diameter,
segments with dense coronary calcification, patients with
heart rates 65 beats/min, and because image noise is a
concern, some obese subjects. The ACCURACY inves-
tigators determined that all study patients with or with-
out obesity (the mean body mass index for the study was
31.4 kg/m2), whether optimal heart rate control (65
beats/min) was achieved, and whether or not there was a
high coronary calcium score (400 or 600 using the
Agatston criteria) were to be included in the final
analysis. The ACCURACY investigators also evaluated
the diagnostic accuracy of CCTA in individuals with
calcium scores above and below 400 and found no clear
reduction in Se, although the Sp clearly was moderately
compromised. The clinical implications for application of
CCTA in symptomatic intermediate risk subjects regard-
less of whether they are optimal candidates are to be
underscored.
he Rest of the Story
he above comments suggest that the time for CCTA to
ule out obstructive coronary disease in symptomatic pa-
ients (regardless of performance site and disease preva-
ence) has arrived, and I would whole-heartedly (pun
ntended) agree (consistent 99% NPV).
However what about ruling in obstructive disease; is
CTA actually a noninvasive coronary arteriogram? Does it
eally have the diagnostic capability at the present time to
efine focal obstructive coronary disease, as we have come to
xpect of conventional diagnostic angiography? The PPV
as only around 50%. I would say, a qualified maybe. The
patial resolution of a conventional angiogram is roughly 0.1
m, and the spatial resolution of 64-slice (and for that catter 256- and 320-slice CCTA) is currently, at best, 0.3
o 0.4 mm. The ever-present cardiac motion and the
resence of focal calcification (not at issue with invasive
ngiography) will continue to compromise the determina-
ion of advanced luminal narrowing by CCTA and will
emain until there are serious improvements in CT detector
echnology.
But, “who wants to be a silly old angiogram, anyway?”
he true power of CCTA lies not in its value as a coronary
rtery stenosis definer, but in its clear and unique noninva-
ive ability as a coronary artery plaque definer. Although the
CCURACY study is confined to reporting the accuracy of
bstructive stenosis definition, the interpretation by the
eaders required evaluation of lesion characteristics, which
ould have included eccentricity or concentricity of calcified
nd noncalcified plaque, the length of the presumed nar-
owing, the estimated minimal luminal diameter/area, and
ubtle changes in contrast opacification before and after the
esion. Furthermore, it is becoming increasingly apparent
hat prognostication using CCTA may be the real long-
erm value of the test, especially in the low to intermediate
isk individual. It has already been noted that the CT
alcium score alone provides incremental prognostic infor-
ation to angiography stenosis severity (4), and that the
omplexity of the plaques identified by CCTA imparts
ignificant information on culprit lesion morphology (5).
he yes-or-no answer to whether or not a symptomatic
atient has obstructive disease remains very clinically
elevant; however, the severity and extent of atherosclerotic
laque is perhaps the ultimate definer of prognosis. The
nitial investigations of Falk (6) from autopsy studies
“. . .the less obstructive plaques gave risk to more occlusions
han did the severely obstructed plaques because of their
uch greater number. . .”) and Kern (7) using intravascular
ltrasound (“Because the aggregate risk of rupture associ-
ted with many nonsignificant lesions exceeds that of the
ewer significant lesions, a myocardial infarction will more
ikely originate from a nonsignificant lesion”) in defining the
ulnerable patient underscore the prognostic importance of
efining plaque severity in at-risk individuals, over and
bove that of defining stenosis.
Leber et al. (8) have suggested that using 64-slice CCTA,
hey may be able to define up to 80% of the total athero-
clerotic burden, but this still remains the Holy Grail of
therosclerosis imaging. All current CT workstation ven-
ors offer a means to define noncalcified plaque. but the
ruth is that the CT densities of fibrous versus lipid-laden
laque using CCTA are too variable and overlapping at
resent to be consistent between subjects (9). Thus, in my
pinion, we still have “miles to go before we sleep” in this
egard. Improvements in temporal and spatial resolution are
till required to elevate CCTA to this lofty goal. But in the
eantime, we can currently define a surrogate to plaque
urden using the established and easily quantified coronary
alcium score in all cardiac CT studies, and we must
ontinue to define, although visually estimated and not
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lex/mixed, and other plaque characteristics on ALL CCTA
eports, because the CCTA promise and ultimate goal is not
ust diagnostics for stenotic lesions but also prognostics in
erms of plaque severity and plaque characteristics.
eprint requests and correspondence: Dr. John A. Rumberger,
ardiovascular Imaging, The Princeton Longevity Center, Prince-
on Forrestall Village, 136 Main Street, Princeton, New Jersey
8540. E-mail: jrumberger@theplc.net.
EFERENCES
. Budoff MJ, Dowe D, Jollis JG, et al. Diagnostic performance of
64-multidetector row coronary computed tomographic angiography for
evaluation of coronary artery stenosis in individuals without known
coronary artery disease: results from the prospective multicenter AC-
CURACY (Assessment by Coronary Computed Tomographic Angiog-
raphy of Individuals Undergoing Invasive Coronary Angiography) trial.
J Am Coll Cardiol 2008;52:1724–32.
. Ferencik M, Ropers D, Abbara S, et al. Diagnostic accuracy of image
postprocessing methods for the detection of coronary artery stenosis by
using multidetector CT. Radiology 2007;243:696–702. M. Budoff MJ, Cohen JC, Garcia MJ, et al. ACCF/AHA clinical compe-
tence statement on cardiac imaging with computed tomography and
magnetic resonance: a report of the American College of Cardiology
Foundation/American Heart Association/American College of Physi-
cians Task Force on Clinical Competence and Training. J Am Coll
Cardiol 2005;46:383–402.
. Keelan PC, Bielak LF, Ashai K, et al. Long-term prognostic value of
coronary calcification detected by electron beam CT in patients under-
going coronary angiography. Circulation 2001;104:412–41.
. Hoffman U, Moselewski F, Nieman K, et al. Noninvasive assessment
of plaque morphology and composition in culprit and stable lesions
in acute coronary syndrome and stable lesions in stable angina by
multidetector computed tomography. J Am Coll Cardiol 2006;47:
1655–62.
. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation
1995;92:657–71.
. Kern MJ, Meier B. Evaluation of the culprit plaque and the physiolog-
ical significance of atherosclerotic narrowing. Circulation 2001;103:
3142–9.
. Leber AW, Becker A, Knez A, et al. Accuracy of 64-slice computed
tomography to classify and quantify plaque volumes in the proximal
coronary system. J Am Coll Cardiol 2006;47:672–7.
. Pohle K, Achenbach S, MacNeill B, et al. Characterization of non-
calcified coronary atherosclerotic coronary plaques by multi-detector
row CT: comparison to IVUS. Atherosclerosis 2007;190:174–80.
ey Words: CT angiography y diagnosis y coronary angiography y
DCT y coronary CTA.
